Journal
JOURNAL OF CLINICAL VIROLOGY
Volume 132, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.jcv.2020.104654
Keywords
Sars CoV-2; Antigen test; Mass-screening; Point-of-care-testing; Cell culture
Categories
Ask authors/readers for more resources
At the time of writing, FIND has listed four CE-marked SARSCoV-2 antigen tests. We evaluated the recently CE -approved rapid POCT SD-Biosensor for SARS-CoV-2 nucleoprotein detection in nasopharyngeal secretions from 330 patients admitted to the Emergency Room for a suspect of COVID-19 and travelers returning home from high risk countries. Sensitivity, specificity, accuracy, negative and predictive values were consistent with the use of the test to mass-screening for SARS-CoV-2 surveillance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available